A 30mg dose for treatment naive patients could be advantageous in several respects. In addition to the probable safety advantage, they could price the drug more competitively, negate impediments to first line approvals in Europe and in the US, and grab more worldwide market share.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.